These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12053327)

  • 1. Catheter closure of atrial septal defects and patent foramen ovale in patients with an atrial septal aneurysm using different devices.
    Krumsdorf U; Keppeler P; Horvath K; Zadan E; Schrader R; Sievert H
    J Interv Cardiol; 2001 Feb; 14(1):49-55. PubMed ID: 12053327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent foramen ovale closure in patients with transient ischemia attack/stroke.
    Sievert H; Horvath K; Zadan E; Krumsdorf U; Fach A; Merle H; Scherer D; Schräder R; Spies H; Nowak B; Lissmann-Jensen H
    J Interv Cardiol; 2001 Apr; 14(2):261-6. PubMed ID: 12053315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients.
    Krumsdorf U; Ostermayer S; Billinger K; Trepels T; Zadan E; Horvath K; Sievert H
    J Am Coll Cardiol; 2004 Jan; 43(2):302-9. PubMed ID: 14736453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm.
    von Bardeleben RS; Richter C; Otto J; Himmrich L; Schnabel R; Kampmann C; Rupprecht HJ; Marx J; Hommel G; Münzel T; Horstick G
    Int J Cardiol; 2009 May; 134(1):33-41. PubMed ID: 18715659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interventional occlusion of foramen ovale and atrial septal defects after paradoxical embolism incidents].
    Beitzke A; Schuchlenz H; Beitzke M; Gamillscheg A; Stein HI; Zartner P
    Z Kardiol; 2002 Sep; 91(9):693-700. PubMed ID: 12448068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transcatheter closure of atrial septal defects in adults. Practicality and safety of four different closure systems used in 102 patients].
    La Rosée K; Krause D; Becker M; Beuckelmann DJ; Deutsch HJ; Höpp HW
    Dtsch Med Wochenschr; 2001 Sep; 126(38):1030-6. PubMed ID: 11565056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of intracardiac echocardiographic guidance in transcatheter closure of atrial septal defects and patent foramen ovale using the Amplatzer device.
    Koenig P; Cao QL; Heitschmidt M; Waight DJ; Hijazi ZM
    J Interv Cardiol; 2003 Feb; 16(1):51-62. PubMed ID: 12664818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.
    Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G
    Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism.
    Khositseth A; Cabalka AK; Sweeney JP; Fortuin FD; Reeder GS; Connolly HM; Hagler DJ
    Mayo Clin Proc; 2004 Jan; 79(1):35-41. PubMed ID: 14708946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.
    Van de Bruaene A; Stroobants D; Benit E
    Acta Cardiol; 2015 Apr; 70(2):133-40. PubMed ID: 26148372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events.
    Windecker S; Wahl A; Chatterjee T; Garachemani A; Eberli FR; Seiler C; Meier B
    Circulation; 2000 Feb; 101(8):893-8. PubMed ID: 10694529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year clinical and echocardiographic evaluation of the Das AngelWings atrial septal occluder.
    Kay JD; O'Laughlin MP; Ito K; Wang A; Bashore TM; Harrison JK
    Am Heart J; 2004 Feb; 147(2):361-8. PubMed ID: 14760337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm.
    Mas JL; Zuber M
    Am Heart J; 1995 Nov; 130(5):1083-8. PubMed ID: 7484740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Percutaneous catheter closure of atrial septal defect. Short-term and mid-term results].
    Bialkowski J; Kusa J; Szkutnik M; Kalarus Z; Banaszak P; Bermúdez-Cañete R; Fernández Pineda L; Zembala M
    Rev Esp Cardiol; 2003 Apr; 56(4):383-8. PubMed ID: 12689573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder).
    Taaffe M; Fischer E; Baranowski A; Majunke N; Heinisch C; Leetz M; Hein R; Bayard Y; Büscheck F; Reschke M; Hoffmann I; Wunderlich N; Wilson N; Sievert H
    Am J Cardiol; 2008 May; 101(9):1353-8. PubMed ID: 18435971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale.
    Earing MG; Cabalka AK; Seward JB; Bruce CJ; Reeder GS; Hagler DJ
    Mayo Clin Proc; 2004 Jan; 79(1):24-34. PubMed ID: 14708945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter device occlusion of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance.
    Salomé N; Braga P; Gonçalves M; Rodrigues A; Ribeiro J; Fonesca C; Pinto F; Ribeiro VG
    Rev Port Cardiol; 2004 May; 23(5):709-17. PubMed ID: 15279455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: no evidence for thrombus deposition with antiplatelet agents.
    Brandt RR; Neumann T; Neuzner J; Rau M; Faude I; Hamm CW
    J Am Soc Echocardiogr; 2002 Oct; 15(10 Pt 1):1094-8. PubMed ID: 12373252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
    Aral M; Mullen M
    Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial).
    Sievert H; Babic UU; Hausdorf G; Schneider M; Höpp HW; Pfeiffer D; Pfisterer M; Friedli B; Urban P
    Am J Cardiol; 1998 Dec; 82(11):1405-13. PubMed ID: 9856928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.